Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
T. Degaga, A. Pasaribu, R. Tripura, Najia Ghanchi +59 more
2026Lancet. Infectious Diseases (Print)13 citations Open access
Semantic Scholar

